Patients with ASXL1 mutations were also younger and more frequently found in the high risk category, suggesting a central role of clonal evolution associated with ASXL1 mutations in CML pathogenesis. Here, ASXL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.